Pharmaceutical company Ikaria Inc. is seeking an exit reportedly worth $2 billion. Private equity firms American Securities LLC, GTCR LLC and Madison Dearborn Partners LLC have tendered their bids to acquire the American specialty drug manufacturer.
Ikaria Inc
Breaking News
Subscribe to VCpost newsletter
Most Popular
- This Crypto Blockchain Emerges as Preferred Platform by Terrorist Groups Like Hamas and Hezbollah
- Despite AI Hype, New Data Shows Only Few US Companies Are Actually Using It
- Apple and Paramount Streaming Bundle Report Spurs Rise in Media Stocks
- Shein Files for US IPO as Chinese-Founded Fashion Giant Seeks to Expand Global Reach
- Amazon Introduces an AI Chatbot for Businessess Called Q
- Germany's Unemployment Rate Rises to Highest Since 2021
- Denmark Set to Remove 1,000 Crown Banknote From Circulation
- US to Prevent China From Supplying Battery Materials for EVs Set to Receive Billions in Tax Credits
